Skip to main content Accessibility help
×
Home

Screening diagnostic candidates from Leishmania infantum proteins for human visceral leishmaniasis using an immunoproteomics approach

Abstract

There is no suitable vaccine against human visceral leishmaniasis (VL) and available drugs are toxic and/or present high cost. In this context, diagnostic tools should be improved for clinical management and epidemiological evaluation of disease. However, the variable sensitivity and/or specificity of the used antigens are limitations, showing the necessity to identify new molecules to be tested in a more sensitive and specific serology. In the present study, an immunoproteomics approach was performed in Leishmania infantum promastigotes and amastigotes employing sera samples from VL patients. Aiming to avoid undesired cross-reactivity in the serological assays, sera from Chagas disease patients and healthy subjects living in the endemic region of disease were also used in immunoblottings. The most reactive spots for VL samples were selected, and 29 and 21 proteins were identified in the promastigote and amastigote extracts, respectively. Two of them, endonuclease III and GTP-binding protein, were cloned, expressed, purified and tested in ELISA experiments against a large serological panel, and results showed high sensitivity and specificity values for the diagnosis of disease. In conclusion, the identified proteins could be considered in future studies as candidate antigens for the serodiagnosis of human VL.

Copyright

Corresponding author

Author for correspondence: Eduardo A. F. Coelho, E-mail: eduardoferrazcoelho@yahoo.com.br

References

Hide All
Alves, F, Bilbe, G, Blesson, S, Goyal, V, Monnerat, S, Mowbray, C, Muthoni, GO, Pécoul, B, Rijal, S, Rode, J, Solomos, A, Strub-Wourgaft, N, Wasunna, M, Wells, S, Zijlstra, EE, Arana, B and Alvar, J (2018) Recent development of visceral leishmaniasis treatments: successes, pitfalls, and perspectives. Clinical Microbiology Reviews 31, e00048.
Bayih, AG, Daifalla, NS and Gedamu, L (2014) DNA-protein immunization using Leishmania peroxidoxin-1 induces a strong CD4+ T cell response and partially protects mice from cutaneous leishmaniasis: role of fusion murine granulocyte-macrophage colony-stimulating factor DNA adjuvant. PLoS Neglected Tropical Diseases 8, e3391.
Brotherton, MC, Racine, G, Foucher, AL, Drummelsmith, J, Papadopoulou, B and Ouellette, M (2010) Analysis of stage-specific expression of basic proteins in Leishmania infantum. Journal of Proteome Research 9, 38423853.
Burza, S, Croft, SL and Boelaert, M (2018) Leishmaniasis. Lancet 392, 951970.
Carrillo, E, Crusat, M, Nieto, J, Chicharro, C, Thomas, MC, Martínez, E, Valladares, B, Cañavate, C, Requena, JM, López, MC, Alvar, J and Moreno, J (2008) Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis. Vaccine 26, 19021911.
Chambers, G, Lawrie, L, Cash, P and Murray, GI (2000) Proteomics: a new approach to the study of disease. The Journal of Pathology 192, 280288.
Chávez-Fumagalli, MA, Schneider, MS, Lage, DP, Machado-de-Ávila, RA and Coelho, EA (2017) An in silico functional annotation and screening of potential drug targets derived from Leishmania spp. hypothetical proteins identified by immunoproteomics. Experimental Parasitology 176, 6674.
Chávez-Fumagalli, MA, Lage, DP, Tavares, GSV, Mendonça, DVC, Dias, DS, Ribeiro, PAF, Ludolf, F, Costa, LE, Coelho, VTS and Coelho, EAF (2019) In silico Leishmania proteome mining applied to identify drug target potential to be used to treat against visceral and tegumentary leishmaniasis. Journal of Molecular Graphics and Modelling 87, 8997.
Coelho, EA, Tavares, CA, Carvalho, FA, Chaves, KF, Teixeira, KN, Rodrigues, RC, Charest, H, Matlashewski, G, Gazzinelli, RT and Fernandes, AP (2003) Immune responses induced by the Leishmania (leishmania) donovani a2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection. Infection and Immunity 71, 39883994.
Coelho, VT, Oliveira, JS, Valadares, DG, Chávez-Fumagalli, MA, Duarte, MC, Lage, PS, Soto, M, Santoro, MM, Tavares, CA, Fernandes, AP and Coelho, EA (2012) Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach. PLoS Neglected Tropical Diseases 6, e1430.
Coulson, RM, Connor, V, Chen, JC and Ajioka, JW (1996) Differential expression of Leishmania major beta-tubulin genes during the acquisition of promastigote infectivity. Molecular and Biochemical Parasitology 82, 227236.
Dias, DS, Martins, VT, Ribeiro, PAF, Ramos, FF, Lage, DP, Tavares, GSV, Mendonça, DVC, Chávez-Fumagalli, MA, Oliveira, JS, Silva, ES, Gomes, DA, Rodrigues, MA, Duarte, MC, Galdino, AS, Menezes-Souza, D and Coelho, EAF (2018) Antigenicity, immunogenicity and protective efficacy of a conserved Leishmania hypothetical protein against visceral leishmaniasis. Parasitology 145, 740751.
Didwania, N, Shadab, M, Sabur, A and Ali, N (2017) Alternative to chemotherapy-the unmet demand against leishmaniasis. Frontiers in Immunology 8, 1779.
Drini, S, Criscuolo, A, Lechat, P, Imamura, H, Skalický, T, Rachidi, N, Lukeš, J, Dujardin, JC and Späth, GF (2016) Species- and strain-specific adaptation of the HSP70 super family in pathogenic Trypanosomatids. Genome Biology and Evolution 8, 19801995.
Duarte, MC, Pimenta, DC, Menezes-Souza, D, Magalhães, RD, Diniz, JL, Costa, LE, Chávez-Fumagalli, MA, Lage, PS, Bartholomeu, DC, Alves, MJ, Fernandes, AP, Soto, M, Tavares, CA, Gonçalves, DU, Rocha, MO and Coelho, EA (2015) Proteins selected in Leishmania (viannia) braziliensis by an immunoproteomic approach with potential serodiagnosis applications for tegumentary leishmaniasis. Clinical and Vaccine Immunology 22, 11871196.
Duarte, MC, Lage, DP, Martins, VT, Costa, LE, Salles, BCS, Carvalho, AMRS, Oliveira, TTS, Dias, DS, Ribeiro, PAF, Chávez-Fumagalli, MA, Machado-de-Ávila, RA, Roatt, BM, Menezes-Souza, D, Magalhães-Soares, DF and Coelho, EAF (2017) Performance of Leishmania braziliensis enolase protein for the serodiagnosis of canine and human visceral leishmaniasis. Veterinary Parasitology 238, 7781.
Ejazi, SA, Bhattacharyya, A, Choudhury, ST, Ghosh, S, Sabur, A, Pandey, K, Das, VNR, Das, P, Rahaman, M, Goswami, RP and Ali, N (2018) Immunoproteomic identification and characterization of Leishmania membrane proteins as non-invasive diagnostic candidates for clinical visceral leishmaniasis. Scientific Reports 8, 12110.
Fernandes, AP, Coelho, EAF, Machado-Coelho, GLL, Grimaldi, J and Gazzinelli, RT (2012) Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives. Current Opinion in Microbiology 15, 110.
Garg, G, Singh, K and Ali, V (2018) Proteomic approaches unravel the intricacy of secreted proteins of Leishmania: an updated review. Biochimica et Biophysica Acta – Proteins and Proteomics 1866, 913923.
Georgiadou, SP, Makaritsis, KP and Dalekos, GN (2015) Leishmaniasis revisited: current aspects on epidemiology, diagnosis and treatment. Journal of Translational Internal Medicine 3, 4350.
Grimaldi, G Jr, Teva, A, Porrozzi, R, Pinto, MA, Marchevsky, RS, Rocha, MG, Dutra, MS, Bruña-Romero, O, Fernandes, AP and Gazzinelli, RT (2014) Clinical and parasitological protection in a Leishmania infantum-macaque model vaccinated with adenovirus and the recombinant A2 antigen. PLoS Neglected Tropical Diseases 8, e2853.
Ishemgulova, A, Kraeva, N, Hlaváčová, J, Zimmer, SL, Butenko, A, Podešvová, L, Leštinová, T, Lukeš, J, Kostygov, A, Votýpka, J, Volf, P and Yurchenko, V (2017) A putative ATP/GTP binding protein affects Leishmania mexicana growth in insect vectors and vertebrate hosts. PLoS Neglected Tropical Diseases 11, e0005782.
Jamal, F, Shivam, P, Kumari, S, Singh, MK, Sardar, AH, Pushpanjali, MS, Narayan, S, Gupta, AK, Pandey, K, Das, VNR, Ali, V, Bimal, S, Das, P and Singh, SK (2017) Identification of Leishmania donovani antigen in circulating immune complexes of visceral leishmaniasis subjects for diagnosis. PLoS One 12, e0182474.
Kapil, S, Singh, PK and Silakari, O (2018) An update on small molecule strategies targeting leishmaniasis. European Journal of Medicinal Chemistry 157, 339367.
Kumar, A and Samant, M (2016) DNA vaccine against visceral leishmaniasis: a promising approach for prevention and control. Parasite Immunology 38, 273281.
Kumar, V, Sharma, M, Rakesh, BR, Malik, CK, Neelagiri, S, Neerupudi, KB, Garg, P and Singh, S (2018) Pyridoxal kinase: a vitamin B6 salvage pathway enzyme from Leishmania donovani. International Journal of Biological Macromolecules 119, 320334.
Kumari, S, Kumar, A, Samant, M, Sundar, S, Singh, N and Dube, A (2008) Proteomic approaches for discovery of new targets for vaccine and therapeutics against visceral leishmaniasis. Proteomics – Clinical Applications 2, 372386.
Lage, DP, Martins, VT, Duarte, MC, Costa, LE, Garde, E, Dimer, LM, Kursancew, AC, Chávez-Fumagalli, MA, Magalhães-Soares, DF, Menezes-Souza, D, Roatt, BM, Machado-de-Ávila, RA, Soto, M, Tavares, CA and Coelho, EA (2016) A new Leishmania-specific hypothetical protein and its non-described specific B cell conformational epitope applied in the serodiagnosis of canine visceral leishmaniasis. Parasitology Research 115, 16491658.
Lang, T, Chastellier, C, Frehel, C, Hellio, R, Metezeau, P, Leão, SS and Antoine, JC (1994) Distribution of MHC class I and of MHC class II molecules in macrophages infected with Leishmania amazonensis. Journal of Cell Science 107, 6982.
Lewis, TS, Hunt, JB, Aveline, LD, Jonscher, KR, Louie, DF, Yeh, JM, Nahreini, TS, Resing, KA and Ahn, NG (2000) Identification of novel MAP kinase pathway signalling targets by functional proteomics and mass spectrometry. Molecular Cell 6, 13431354.
Lima, MP, Costa, LE, Duarte, MC, Menezes-Souza, D, Salles, BCS, Santos, TTO, Ramos, FF, Chávez-Fumagalli, MA, Kursancew, ACS, Ambrósio, RP, Roatt, BM, Machado-de-Ávila, RA, Gonçalves, DU and Coelho, EAF (2017) Evaluation of a hypothetical protein for serodiagnosis and as a potential marker for post-treatment serological evaluation of tegumentary leishmaniasis patients. Parasitology Research 116, 11971206.
Magalhães, RD, Duarte, MC, Mattos, EC, Martins, VT, Lage, PS, Chávez-Fumagalli, MA, Lage, DP, Menezes-Souza, D, Régis, WC, Alves, MJ, Soto, M, Tavares, CA, Nagen, RA and Coelho, EA (2014) Identification of differentially expressed proteins from Leishmania amazonensis associated with the loss of virulence of the parasites. PLoS Neglected Tropical Diseases 8, e2764.
Martins, VT, Chávez-Fumagalli, MA, Costa, LE, Canavacci, AM, Martins, AM, Lage, PS, Lage, DP, Duarte, MC, Valadares, DG, Magalhães, RD, Ribeiro, TG, Nagem, RA, DaRocha, WD, Régis, WC, Soto, M, Coelho, EA, Fernandes, AP and Tavares, CA (2013) Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis. PLoS Neglected Tropical Diseases 7, e2148.
Maspi, N, Ghaffarifar, F, Sharifi, Z and Dalimi, A (2015) Cloning and constructing a plasmid encoding Leishmania eukaryotic initiation factor gene of Leishmania major fused with green fluorescent protein gene as a vaccine candidate. West Indian Medical Journal 65, 256259.
Mishra, A, Khan, MI, Jha, PK, Kumar, A, Das, S, Das, P and Sinha, KK (2018) Oxidative stress-mediated overexpression of uracil DNA glycosylase in Leishmania donovani confers tolerance against antileishmanial drugs. Oxidative Medicine and Cellular Longevity 2018, 4074357.
Moreira, DS, Pescher, P, Laurent, C, Lenormand, P, Späth, GF and Murta, SM (2015) Phosphoproteomic analysis of wild-type and antimony-resistant Leishmania braziliensis lines by 2D-DIGE technology. Proteomics 15, 29993019.
Moreira, VR, Jesus, LCL, Soares, RP, Silva, LDM, Pinto, BAS, Melo, MN, Paes, AMA and Pereira, SRF (2017) Meglumine antimoniate (glucantime) causes oxidative stress-derived DNA damage in BALB/c mice infected by Leishmania (Leishmania) infantum. Antimicrobial Agents and Chemotherapy 61, e02360.
Mortazavidehkordi, N, Farjadfar, A, Khanahmad, H, Najafabadi, ZG, Hashemi, N, Fallah, A, Najafi, A, Kia, V and Hejazi, SH (2016) Evaluation of a novel lentiviral vaccine expressing KMP11-HASPB fusion protein against Leishmania infantum in BALB/c mice. Parasite Immunology 38, 670677.
Mukherjee, I, Chakraborty, A and Chakrabarti, S (2016) Identification of internalin-A-like virulent proteins in Leishmania donovani. Parasite & Vectors 9, 557.
Nandan, D, Thomas, SA, Nguyen, A, Moon, KM, Foster, LJ and Reiner, NE (2017) Comprehensive identification of mRNA-binding proteins of Leishmania donovani by interactome capture. PLoS One 12, e0170068.
Neuhoff, V, Arold, N, Taube, D and Ehrhardt, W (1988) Improved staining of proteins in polyacrilamide gels including isoeletric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 9, 255262.
Nico, D, Claser, C, Borja-Cabrera, GP, Travassos, LR, Palatnik, M, Soares, IS, Rodrigues, MM and Palatnik-de-Sousa, CB (2010) Adaptive immunity against Leishmania nucleoside hydrolase maps its c-terminal domain as the target of the CD4+ T cell-driven protective response. PLoS Neglected Tropical Diseases 4, e866.
Rajão, MA, Furtado, C, Alves, CL, Passos-Silva, DG, Moura, MB, Schamber-Reis, BL, Kunrath-Lima, M, Zuma, AA, Vieira-da-Rocha, JP, Garcia, JB, Mendes, IC, Pena, SD, Macedo, AM, Franco, GR, Souza-Pinto, NC, Medeiros, MH, Cruz, AK, Motta, MC, Teixeira, SM and Machado, CR (2014) Unveiling Benznidazole's mechanism of action through overexpression of DNA repair proteins in Trypanosoma cruzi. Environmental and Molecular Mutagenesis 55, 309321.
Ribeiro, PAF, Dias, DS, Novais, MVM, Lage, DP, Tavares, GSV, Mendonça, DVC, Oliveira, JS, Chávez-Fumagalli, MA, Roatt, BM, Duarte, MC, Menezes-Souza, D, Ludolf, F, Tavares, CAP, Oliveira, MC and Coelho, EAF (2018) A Leishmania hypothetical protein-containing liposome-based formulation is highly immunogenic and induces protection against visceral leishmaniasis. Cytokine 111, 131139.
Sabur, A, Bhowmick, S, Chhajer, R, Ejazi, SA, Didwania, N, Asad, M, Bhattacharyya, A, Sinha, U and Ali, N (2018) Liposomal elongation factor-1α triggers effector CD4 and CD8 T cells for induction of long-lasting protective immunity against visceral leishmaniasis. Frontiers in Immunology 9, 18.
Sakkas, H, Gartzonika, C and Levidiotou, S (2016) Laboratory diagnosis of human visceral leishmaniasis. Journal of Vectors Borne Diseases 53, 816.
Santos, TTO, Martins, VT, Lage, DP, Costa, LE, Salles, BCS, Carvalho, AMRS, Dias, DS, Ribeiro, PAF, Chávez-Fumagalli, MA, Machado-de-Ávila, RA, Roatt, BM, Magalhães-Soares, DF, Menezes-Souza, D, Coelho, EAF and Duarte, MC (2017) Probing the efficacy of a heterologous Leishmania/l. Viannia braziliensis recombinant enolase as a candidate vaccine to restrict the development of L. infantum in BALB/c mice. Acta Tropica 171, 816.
Sundar, S and Singh, OP (2018) Molecular diagnosis of visceral leishmaniasis. Molecular Diagnosis & Therapy 22, 443457.
Torres-Guerrero, E, Quintanilla-Cedillo, MR, Ruiz-Esmenjaud, J and Arenas, R (2017) Leishmaniasis: a review. F1000Research 6, 750.
Valadares, DG, Duarte, MC, Oliveira, JS, Chávez-Fumagalli, MA, Martins, VT, Costa, LE, Leite, JP, Santoro, MM, Régis, WC, Tavares, CA and Coelho, EA (2011) Leishmanicidal activity of the Agaricus blazei murill in different Leishmania species. Parasitology International 60, 357363.
Vijayakumar, S and Das, P (2018) Recent progress in drug targets and inhibitors towards combating leishmaniasis. Acta Tropica 181, 95104.
Vlahou, A and Fountoulakis, M (2005) Proteomic approaches in the search for disease biomarkers. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 814, 1119.
World Health Organization (2016) Leishmaniasis. Available at http://www.who.int/topics/leishmaniasis/en/.

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed